Jobs / United States / Pfizer INC
Senior Manager, Performance Analytics & Insights, Oncology - Breast Cancer
Pfizer INC · 🇺🇸 4 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles3 certified filings for “SENIOR MANAGER, STATISTICAL PROGRAMMING” (Statisticians) in CA: $171k–$214k, median $208k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
Senior Manager, Performance Analytics & Insights Oncology | Breast Cancer | Global Commercial Analytics About the Team Global Commercial Analytics (GCA) harnesses the power of data to drive robust analytical insights that inform some of Pfizer’s most critical business decisions. Within Oncology, our Performance Analytics & Insights (PAI) team translates complex secondary data into commercial strategy, connecting what the data says to what the business does. We sit at the intersection of brand strategy, patient access, and business performance — and our work directly shapes how Pfizer’s oncology portfolio reaches the patients who need it most. Role Summary We are seeking a Senior Manager of Performance Analytics & Insights to support the breast cancer franchise within Oncology. This role is accountable for tracking and interpreting commercial performance across the breast cancer portfolio — including brand demand, market share, biomarker-defined patient segments, and subnational performance patterns — and translating those insights into clear, actionable narratives for brand teams and senior leadership. This is a high-visibility, fast-paced role requiring strong analytical capability, business judgment, and the ability to communicate compellingly with commercial and GCA stakeholders who are focused on driving outcomes. The right candidate is intellectually curious, commercially grounded, comfortable operating in a complex matrixed environment, and actively embraces AI and emerging tools to work smarter and faster. Role Responsibilities Performance Measurement & Insights • Own end-to-end performance reporting for the breast cancer portfolio, including brand sales, TRx/NPS, market share, and attainment vs. targets across weekly, monthly, and quarterly cadences. • Leverage secondary data sources (e.g., IQVIA, Symphony, specialty pharmacy, hub/SP data) to identify trends, surface risks and opportunities, and connect data signals to brand strategy decisions. • Analyze performance through the lens of defined patient segments — including histology, biomarkers, patient demographics, lines of therapy, etc. — to understand how disease biology and treatment history shapes market dynamics, prescribing patterns, and patient flow across the treatment landscape. • Apply subnational analytics to identify geographic variation in brand performance, patient segment penetration, and market dynamics — surfacing actionable insights for brand strategy without ownership of field operations or execution. • Translate analytical findings into clear business narratives — leading with the so what and driving toward actionable recommendations for brand teams and leadership. • Support the development and maintenance of the Oncology LT Dashboard and other enterprise reporting infrastructure, ensuring breast cancer metrics are accurate, timely, and decision-ready. • Proactively identifying data anomalies, validating analytical outputs, and ensuring every insight delivered to stakeholders is accurate and reliable. Brand Strategy Support • Serve as the secondary data analytics partner for the breast cancer team, providing data-driven inputs that inform brand positioning, strategic planning, and commercial decision-making. • Partner with forecasting teams to provide accurate secondary data inputs — including demand trends, patient segment sizing, and market share dynamics — that inform volume and revenue projections. • Identify emerging trends in the breast cancer treatment landscape — including evolving biomarker testing rates, treatment sequencing patterns, and competitive dynamics — and proactively frame the commercial implications for brand leadership. • Partner with insights and strategy team members to connect patient journey data to brand strat